|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Michael Lübbert , Peter A. JonesPublisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K Edition: Softcover reprint of the original 1st ed. 2014 Dimensions: Width: 15.50cm , Height: 1.80cm , Length: 23.50cm Weight: 5.095kg ISBN: 9783662519288ISBN 10: 3662519283 Pages: 325 Publication Date: 24 September 2016 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsReviewsFrom the reviews: This new book covers the timely topic of epigenetic therapy. ... The combination of articles describing the basic science framework of epigenetics and the detailed summaries of clinical trials with epigenetic drugs is attractive for a wide readership, ranging from medical students to scientists who are interested in translational studies to clinicians who work for the direct benefit of cancer patients. ... This high-quality book is an excellent overview of the current success and future promise of epigenetic therapy. (Gerd Pfeifer, Doody's Book Reviews, May, 2014) From the reviews: “This new book covers the timely topic of epigenetic therapy. … The combination of articles describing the basic science framework of epigenetics and the detailed summaries of clinical trials with epigenetic drugs is attractive for a wide readership, ranging from medical students to scientists who are interested in translational studies to clinicians who work for the direct benefit of cancer patients. … This high-quality book is an excellent overview of the current success and future promise of epigenetic therapy.” (Gerd Pfeifer, Doody’s Book Reviews, May, 2014) From the reviews: This new book covers the timely topic of epigenetic therapy. ... The combination of articles describing the basic science framework of epigenetics and the detailed summaries of clinical trials with epigenetic drugs is attractive for a wide readership, ranging from medical students to scientists who are interested in translational studies to clinicians who work for the direct benefit of cancer patients. ... This high-quality book is an excellent overview of the current success and future promise of epigenetic therapy. (Gerd Pfeifer, Doody's Book Reviews, May, 2014) Author InformationTab Content 6Author Website:Countries AvailableAll regions |